These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 34836386)
1. Clinical Presentation of Celiac Disease and Diagnosis Accuracy in a Single-Center European Pediatric Cohort over 10 Years. Di Biase AR; Marasco G; Ravaioli F; Colecchia L; Dajti E; Lecis M; Passini E; Alemanni LV; Festi D; Iughetti L; Colecchia A Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836386 [TBL] [Abstract][Full Text] [Related]
2. Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice. Werkstetter KJ; Korponay-Szabó IR; Popp A; Villanacci V; Salemme M; Heilig G; Lillevang ST; Mearin ML; Ribes-Koninckx C; Thomas A; Troncone R; Filipiak B; Mäki M; Gyimesi J; Najafi M; Dolinšek J; Dydensborg Sander S; Auricchio R; Papadopoulou A; Vécsei A; Szitanyi P; Donat E; Nenna R; Alliet P; Penagini F; Garnier-Lengliné H; Castillejo G; Kurppa K; Shamir R; Hauer AC; Smets F; Corujeira S; van Winckel M; Buderus S; Chong S; Husby S; Koletzko S; Gastroenterology; 2017 Oct; 153(4):924-935. PubMed ID: 28624578 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the ESPGHAN Celiac Guidelines in a North American Pediatric Population. Gidrewicz D; Potter K; Trevenen CL; Lyon M; Butzner JD Am J Gastroenterol; 2015 May; 110(5):760-7. PubMed ID: 25823767 [TBL] [Abstract][Full Text] [Related]
4. Prospective Evaluation of the ESPGHAN Guidelines for Diagnosis of Celiac Disease in New Zealand Children. Bishop J; Reed P; Austin P; Hurst M; Ameratunga R; Craigie A; McFarlane J; Chin SE; Mouat SM; Evans HM J Pediatr Gastroenterol Nutr; 2018 Dec; 67(6):749-754. PubMed ID: 29916948 [TBL] [Abstract][Full Text] [Related]
5. Are ESPGHAN "biopsy-sparing" guidelines for celiac disease also suitable for asymptomatic patients? Trovato CM; Montuori M; Anania C; Barbato M; Vestri AR; Guida S; Oliva S; Mainiero F; Cucchiara S; Valitutti F Am J Gastroenterol; 2015 Oct; 110(10):1485-9. PubMed ID: 26372508 [TBL] [Abstract][Full Text] [Related]
6. Assessment of European Society of Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) guidelines in an Australian paediatric population. Thompson G; Grover Z; Loh R; Mews C; Ravikumara M; Jevon G; D'Orsogna L; McLean-Tooke A Pathology; 2020 Aug; 52(5):568-575. PubMed ID: 32586687 [TBL] [Abstract][Full Text] [Related]
7. Interpretation and implementation of the revised European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) guidelines on pediatric celiac disease amongst consultant general pediatricians in Southwest of England. Paul SP; Adams HL; Basude D; Indian J Gastroenterol; 2019 Jun; 38(3):203-210. PubMed ID: 31183842 [TBL] [Abstract][Full Text] [Related]
8. Celiac disease can be predicted by high levels of anti-tissue transglutaminase antibodies in population-based screening. Webb C; Norström F; Myléus A; Ivarsson A; Halvarsson B; Högberg L; Lagerqvist C; Rosén A; Sandström O; Stenhammar L; Carlsson A J Pediatr Gastroenterol Nutr; 2015 Jun; 60(6):787-91. PubMed ID: 25564816 [TBL] [Abstract][Full Text] [Related]
9. Coeliac disease in the ERA of the new ESPGHAN and BSPGHAN guidelines: a prospective cohort study. Benelli E; Carrato V; Martelossi S; Ronfani L; Not T; Ventura A Arch Dis Child; 2016 Feb; 101(2):172-6. PubMed ID: 26578746 [TBL] [Abstract][Full Text] [Related]
10. Prudence is necessary in the application of the new ESPGHAN criteria for celiac disease omitting duodenal biopsy: a case report. Schirru E; Jores RD; Congia M Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):679-80. PubMed ID: 24694761 [TBL] [Abstract][Full Text] [Related]
11. Evaluating diagnostic accuracy of anti-tissue Transglutaminase IgA antibodies as first screening for Celiac Disease in very young children. Frulio G; Polimeno A; Palmieri D; Fumi M; Auricchio R; Piccolo E; Carandente Giarrusso P Clin Chim Acta; 2015 Jun; 446():237-40. PubMed ID: 25944768 [TBL] [Abstract][Full Text] [Related]
12. ESPGHAN 'biopsy-sparing' guidelines for celiac disease in children with low antitransglutaminase during COVID-19. Trovato CM; Montuori M; Cucchiara S; Oliva S Eur J Gastroenterol Hepatol; 2020 Dec; 32(12):1523-1526. PubMed ID: 32956181 [TBL] [Abstract][Full Text] [Related]
13. IMPROVED ADHERENCE TO THE ESPGHAN GUIDELINES IS NECESSARY FOR DIAGNOSING CELIAC DISEASE IN CHILDREN: A SINGLE-CENTER EXPERIENCE. Lau WS; Heaton PA; Paul SP Arq Gastroenterol; 2021; 58(2):164-167. PubMed ID: 34190779 [TBL] [Abstract][Full Text] [Related]
14. Evidence Supporting Serology-based Pathway for Diagnosing Celiac Disease in Asymptomatic Children From High-risk Groups. Paul SP; Sandhu BK; Spray CH; Basude D; Ramani P J Pediatr Gastroenterol Nutr; 2018 Apr; 66(4):641-644. PubMed ID: 28957985 [TBL] [Abstract][Full Text] [Related]
15. Role of serological tests in the diagnosis of coeliac disease in children in New Zealand. Ho SS; Keenan JI; Day AS J Paediatr Child Health; 2020 Dec; 56(12):1906-1911. PubMed ID: 32946186 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of a new point-of-care screening assay for celiac disease. Benkebil F; Combescure C; Anghel SI; Besson Duvanel C; Schäppi MG World J Gastroenterol; 2013 Aug; 19(31):5111-7. PubMed ID: 23964145 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of a point-of-care test based on deamidated gliadin peptides for the detection of celiac disease in pediatric patients. Polanco I; Koester Weber T; Martínez-Ojinaga E; Molina M; Sarria J Rev Esp Enferm Dig; 2017 Nov; 109(11):743-748. PubMed ID: 28950706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]